Identification and Exploration of Herb-Drug Combinations Used By Cancer Patients
Open Access
- 27 January 2009
- journal article
- research article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 8 (1) , 29-36
- https://doi.org/10.1177/1534735408330202
Abstract
Introduction: This survey aims to identify herb-chemotherapeutic drug combinations in a defined group of cancer patients and to explore possible clinical consequences of these combinations. Methods: Herb-chemotherapeutic drug combinations were identified among adult cancer patients, and clinical consequences of the combinations were explored by literature searches in medical databases on possible mutual effects on similar cytochrome P-450 metabolising enzymes (CYPs) and/or the P-glycoprotein (P-gp) transporter. Results: Among 42 cancer patients using herbal remedies concurrently with chemotherapy, 136 two-agent herb-drug combinations were registered and 47 different potential herb-drug interactions were identified on the level of CYP metabolism and P-gp transport in vitro. Garlic, ginger, green tea and noni juice were the herbal remedies most frequently used in such combinations. For 48 % of the herbal remedies identified no literature data exist on their interaction potentials. Clinical studies were available for four herbal remedies only. Minor clinical potential for CYP interactions in humans was indicated for green tea and Echinacea. P-gp interactions were only investigated for garlic, which showed a significant interaction potential both in vivo and in vitro. Conclusion: The large number of in vitro potential herb-drug interactions identified urge for more clinical pharmacokinetic interaction studies in humans.Keywords
This publication has 40 references indexed in Scilit:
- Inhibition of P-glycoprotein in Caco-2 cells: Effects of herbal remedies frequently used by cancer patientsXenobiotica, 2008
- Herbal use among cancer patients during palliative or curative chemotherapy treatment in NorwaySupportive Care in Cancer, 2008
- Lesson From Comparison of CAM Use by Women With Female-Specific Cancers to Others: It's Time to Focus on Interaction Risks With CAM TherapiesIntegrative Cancer Therapies, 2007
- Potential Interactions Between Complementary/Alternative Products and Conventional Medicines in a Medicare PopulationAnnals of Pharmacotherapy, 2007
- Influence of Garlic (Allium sativum) on the Pharmacokinetics of DocetaxelClinical Cancer Research, 2006
- Induction of CYP1A by Green Tea Extract in Human Intestinal Cell LinesPlanta Medica, 2006
- The Inhibition of Human Cytochrome P450 by Ethanol Extracts of North American BotanicalsPharmaceutical Biology, 2006
- GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERSDrug Metabolism and Disposition, 2004
- Final results of the EORTC 18871/DKG 80-1 randomised phase III trial: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasisPublished by Elsevier ,2004
- The interaction between St John's wort and an oral contraceptiveClinical Pharmacology & Therapeutics, 2003